Graph Blockchain’s (GBLC.C) story is either going to be one of ultimate failure—an object lesson of what not to do for new companies—or an absolutely great comeback story, but what’s obvious is that they’re not willing to fly the white flag anytime soon.
-
-
Captiva Verde (PWR.C): If Canadian shrooms aren’t legal, do business in Mexico
As we wait for the Canadian courts to repeat the process that made cannabis legal after decades in purgatory, some companies aren’t waiting around for their chance to claim a piece of the upcoming shroomaceuticals market.
-
Yield Growth Corp (BOSS.C) subsidiary takes on 18% of shroom clinical trial outfit
CBD product developer/retailer Yield Growth Corp (BOSS.C) has announced it has agreed to acquire 18% of Translational Life Sciences, a company that “aims to develop proprietary formulations using restricted substances to focus on unmet medical needs in opioid dependence, psychotic illness, pain management and traumatic brain injury, including concussion.”
-
Yield Growth (BOSS.C) subsidiary Flourish Mushrooms forms JV to do research and development in paradise
Flourish Mushroom Labs, a subsidiary of Yield Growth (BOSS.C), entered into a binding letter of intent with Acres Agricultural Canada to form a JV in Saint Vincent and the Grenadines for the cultivation of psilocybin mushrooms, and for research and development into compounds and therapeutic uses for psychedelic mushrooms.
-
Yield Growth (BOSS.C) files a patent for mushrooms as weight loss, and begins tasting trials
Yield Growth’s (BOSS.C) subsidiary, Flourish Mushroom Labs, has filed a U.S. patent application in the United States for the invention relating to methods of using serotonin antagonists, and in particular, psychedelic mushroom actives, for weight loss.
